All our tumor samples will also be examined for somatic mutations since these are also detected in 30% of sporadic HNPGLs, mainly involving VHL, NF1, RET and HIF2α genes [5], although these are rarely associated with multiple HNPGLs. The gene discussed is EPAS1; the disease is neoplasm.